Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: Protective effect of catechol-O- methyltransferase

International Journal of Cancer

Volumn 123, Issue 6, 2008, Pages 1246-1254

  Salama, Salama A ^a   Kamel, Marwa ^a,b   Awad, Mohamed ^a   Nasser, Abdel Hakim Ben ^a   Al Hendy, Ayman ^a   Botting, Shaleen ^a   Arrastia, Concepcion ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Catecholestrogens; COMT; Endometrial cancer; Genomic instability

Indexed keywords

2 HYDROXYESTRADIOL; 4 HYDROXYESTRADIOL; CATECHOL ESTROGEN; CATECHOL METHYLTRANSFERASE;

ARTICLE; CANCER PREVENTION; CANCER RISK; CARCINOGENICITY; CELL IMMORTALIZATION; CELL PROLIFERATION; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; GENE FUNCTION; GENE OVEREXPRESSION; HORMONAL CARCINOGENESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; LONG TERM EXPOSURE; MALIGNANT TRANSFORMATION; MICROSATELLITE INSTABILITY; OXIDATIVE STRESS; PRIORITY JOURNAL;

CATECHOL O-METHYLTRANSFERASE; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIUM; EPITHELIAL CELLS; ESTROGENS, CATECHOL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; MICROSATELLITE INSTABILITY; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 49749104328     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23653     Document Type: Article

References (59)

1. Shang YF. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nat Rev Cancer 2006;6:360-8.
2. Sonoda Y, Barakat RR. Screening and the prevention of gynecologic cancer: endometrial cancer. Best Pract Res Clin Obstet Gynaecol 2006;20:363-77.
3. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer: review of the evidence and research perspectives. Ann N Y Acad Sci 2001;943:296-315.
4. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366:491-505.
5. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000;13:295-308.
6. Key TJA, Pike MC. The dose-effect relationship between unopposed estrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk. Br J Cancer 1988;57:205-12.
7. Prokai-Tatrai K, Prokai L. Impact of metabolism on the safety of estrogen therapy. Ann N Y Acad Sci 2005;1052:243-57.
8. Henderson BE, Feigelson HS. Hormonal carcinogenesis. Carcinogenesis 2000;21:427-33.
9. Bocchinfuso WP, Korach KS. Mammary gland development and tumorigenesis in estrogen receptor knockout mice. J Mammary Gland Biol Neoplasia 1997;2:323-34.
10. Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS. A mouse mammary tumor virus Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha. Cancer Res 1999;59:1869-76.
11. Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WR, Korach KS, Devanesan P, Todorovic R, Rogan EG, Cavalieri EL. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis. J Steroid Biochem Mol Biol 2003;86:477-86.
12. Liehr JG. Hormone-associated cancer: mechanistic similarities between human breast cancer and estrogen-induced kidney carcinogenesis in hamsters. Environ Health Perspect 1997;105(Suppl 3):565-9.
13. Cuendet M, Liu XM, Pisha E, Li Y, Yao JQ, Yu LN, Bolton JL. Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression. Mut Res 2004;550:109-21.
14. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 2003;100:3913-8.
15. Tsuchiya Y, Nakajima M, Yokoi T. Cytochrome P450-mediated metabolism of estrogens and its regulation in human. Cancer Lett 2005;227:115-24.
16. Stack DE, Byun J, Gross ML, Rogan EG, Cavalieri EL. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem Res Toxicol 1996;9:851-9.
17. Cavalieri EL, Li KM, Balu N, Saeed M, Devanesan P, Higginbotham S, Zhao J, Gross ML, Rogan EG. Catechol ortho-quinones: the electrophilic compounds that form depurinating DNA adducts and could initiate cancer and other diseases. Carcinogenesis 2002;23:1071-7.
18. Patel MM, Bhat HK. Differential oxidant potential of carcinogenic and weakly carcinogenic estrogens: involvement of metabolic activation and cytochrome P450. J Biochem Mol Toxicol 2004;18:37-42.
19. Liehr JG, Roy D. Free-radical generation by redox cycling of estrogens. Free Rad Biol Med 1990;8:415-23.
20. Kovacic P, Jacintho JD. Mechanisms of carcinogenesis: focus on oxidative stress and electron transfer. Curr Med Chem 2001;8:773-96.
21. Russo J, Fernandez SV, Russo PA, Fernbaugh R, Sheriff FS, Lareef HM, Garber J, Russo IH. 17-beta-estradiol induces transformation and tumorigenesis in human breast epithelial cells. FASEB J 2006;20:1622-34.
22. Liehr JG, Avitts TA, Randerath E, Randerath K. Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc Natl Acad Sci USA 1986;83:5301-5.
23. Li JJ, Li SA. Estrogen carcinogenesis in Syrian-hamster tissues: role of metabolism. Fed Proc 1987;46:1858-63.
24. Newbold RR, Liehr JG. Induction of uterine adenocarcinoma in CD-1 mice by catechol estrogens. Cancer Res 2000;60:235-7.
25. Bertocci B, Garotta G, Daprada M, Lahm HW, Zurcher G, Virgallita G, Miggiano V. Immunoaffinity purification and partial amino acid sequence analysis of catechol-O-methyltransferase from pig liver. Biochim Biophys Acta 1991;1080:103-9.
26. Yager JD, Liehr JG. Molecular mechanisms of estrogen carcinogenesis. Ann Rev Pharmacol Toxicol 1996;36:203-32.
27. Cavalieri EL, Stack DE, Devanesan PD, Todorovic R, Dwivedy I, Higginbotham S, Johansson SL, Patil KD, Gross ML, Gooden JK, Ramanathan R, Cerny RL, et al. Molecular origin of cancer: catechol estrogen-3,4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997;94:10937-42.
28. Sasaki M, Kaneuchi M, Sakuragi N, Dahiya R. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Cancer Res 2003;63:3101-6.
29. Wentz MJ, Al-Hendy A. Hormonal regulation of catechol-O-methyl transferase expression in human myometrial cells. J Soc Gynecol Investig 2006;13:240A-1.
30. Mannisto PT, Kaakkola S. Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev 1999;51:593-628.
31. Zhu BT, Liehr JG. Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin: possible role in estradiol-induced tumorigenesis. J Biol Chem 1996;271:1357-63.
32. Kyo S, Nakamura M, Kiyono T, Maida Y, Kanaya T, Tanaka M, Yatabe N, Inoue M. Successful immortalization of endometrial glandular cells with normal structural and functional characteristics. Am J Pathol 2003;163:2259-69.
33. Pisha E, Lui XM, Constantinou AI, Bolton JL. Evidence that a metabolite of equine estrogens, 4-hydroxyequilenin, induces cellular transformation in vitro. Chem Res Toxicol 2001;14:82-90.
34. Russo J, Lareef MH, Tahin Q, Hu YF, Slater C, Ao X, Russo IH. 17 beta-estradiol is carcinogenic in human breast epithelial cells. J Steroid Biochem Mol Biol 2002;80:149-62.
35. Hassan MH, Salama SA, Arafa HM, Hamada FM, Al-Hendy A. Adenovirus-mediated delivery of a dominant-negative estrogen receptor gene in uterine leiomyoma cells abrogates estrogen- and progesterone-regulated gene expression. J Clin Endocrinol Metab 2007;92:3949-57.
36. Salama SA, Jamaluddin M, Kumar R, Hassan MH, Al-Hendy A. Progesterone regulates catechol-O-methyl transferase gene expression in breast cancer cells: distinct effect of progesterone receptor isoforms. J Steroid Biochem Mol Biol 2007;107:253-61.
37. Rothe G, Valet G. Flow cytometric analysis of respiratory burst activity in phagocytes with hydroethidine and 2′,7′-dichlorofluorescin. J Leukoc Biol 1990;47:440-8.
38. Hecht JL, Mutter GL. Molecular and pathologic aspects of endometrial carcinogenesis. J Clin Oncol 2006;24:4783-91.
39. Russo J, Lareef AH, Balogh G, Guo S, Russo IH. Estrogen and its metabolites are carcinogenic agents in human breast epithelial cells. J Steroid Biochem. Mol Biol 2003;87:1-25.
40. Lareef MH, Garber J, Russo PA, Russo IH, Heulings R, Russo J. The estrogen antagonist ICI-182-780 does not inhibit the transformation phenotypes induced by 17-beta-estradiol and 4-OH estradiol in human breast epithelial cells. Int J Oncol 2005;26:423-9.
41. Fernandez SV, Russo IH, Lareef M, Balsara B, Russo J. Comparative genomic hybridization of human breast epithelial cells transformed by estrogen and its metabolites. Int J Oncol 2005;26:691-5.
42. Hirose Y, Tsutsui TW, Ohno M, Barrett JC, Tsutsui T. Effects of a catechol-O-methyltransferase inhibitor on catechol estrogen-induced cellular transformation, chromosome aberrations and apoptosis in Syrian hamster embryo cells. Int J Cancer 2007;120:1627-33.
43. Muzandu K, Shaban Z, Ishizuka M, Kazusaka A, Fujita S. Nitric oxide enhances catechol estrogen-induced oxidative stress in LNCaP cells. Free. Rad Res 2005;39:389-98.
44. Skinner AM, Turker MS. Oxidative mutagenesis, mismatch repair, and aging. Sci Aging Knowledge Environ 2005;9:1-9.
45. Bellacosa A. Functional interactions and signaling properties of mammalian DNA mismatch repair proteins. Cell Death Differ 2001;8:1076-92.
46. Maneval ML, Eckert KA. Effects of oxidative and alkylating damage on microsatellite instability in nontumorigenic human cells. Mutat Res 2004;546:29-38.
47. Lu F, Zahid M, Saeed M, Cavalieri EL, Rogan EG. Estrogen metabolism and formation of estrogen-DNA adducts in estradiol-treated MCF-10F cells. The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin induction and catechol-O-methyltransferase inhibition. J Steroid Biochem Mol Biol 2007.
48. Lin PH, Nakamura J, Yamaguchi S, Asakura S, Swenberg JA. Aldehydic DNA lesions induced by catechol estrogens in calf thymus DNA. Carcinogenesis 2003;24:1133-41.
49. Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: keynote lecture. Ann N Y Acad Sci 2006;1089:286-301.
50. Cavalieri E, Frenkel K, Liehr JG, Rogan E, Roy D. Estrogens as endogenous genotoxic agents: DNA adducts and mutations. In: Cavalieri E, Rogan E, eds. JNCI monograph: estrogens as endogenous carcinogens in the breast and prostate. New York: Oxford Press, 2000:75-93.
51. Zhao Z, Kosinska W, Khmelnitsky M, Cavalieri EL, Rogan EG, Chakravarti D, Sacks PG, Guttenplan JB. Mutagenic activity of 4-hydroxyestradiol, but not 2-hydroxyestradiol, in BB rat2 embryonic cells, and the mutational spectrum of 4-hydroxyestradiol. Chem Res Toxicol 2006;19:475-9.
52. Seeger H, Wallwiener D, Kraemer E, Mueck AO. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cell. Maturitas 2006;54: 72-7.
53. Zhu BT. Catechol-O-Methyltransferase (COMT)-mediated methylation metabolism of endogenous bioactive catechols and modulation by endobiotics and xenobiotics: importance in pathophysiology and pathogenesis. Curr Drug Metab 2002;3:321-49.
54. Dubey RK, Jackson EK, Gillespie DG, Rosselli M, Barchiesi F, Krust A, Keller H, Zacharia LC, Imthurn B. Cytochromes 1A1/1B1-and catechol -O-methyltransferase-derived metabolites mediate estradiol-induced antimitogenesis in human cardiac fibroblast. J Clin Endocrinol Metab 2005;90:247-55.
55. Doherty JA, Weiss NS, Freeman RJ, Dightman DA, Thornton PJ, Houck JR, Voigt LF, Rossing MA, Schwartz SM, Chen C. Genetic factors in catechol estrogen metabolism in relation to the risk of endometrial cancer. Cancer Epidemiol Biomarkers Prev 2005;14:357-66.
56. Zhu BT, Conney AH. Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res 1998;58:2269-77.
57. Zhao XM, Xie MQ, Yang DZ, Wang LA, Li SJ, Zhuang YY, Tang XL. Polymorphism of catechol-O-methyltransferase gene in relation to the risk of endometrial cancer. Zhonghua Fu Chan Ke Za Zhi 2007;42:116-9.
58. Pike MC, Spicer DV, Dahmoush L, Press MF. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk. Epidemiol Rev 1993;15:17-35.
59. Salih S, Salama SA, Jamaluddin M, Fadl AA, Blok LJ, Burger CW, Nagamani M, Al Hendy A. Progesterone-mediated regulation of catechol -O-methyltransferase expression in endometrial cancer cells. Reprod Sci 2008;15:210-20.